Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837379 · ClinicalTrials.gov registry record · NA
Goal2Quit + NRT Sampling
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT03837379 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 164 participants.
The verdict
NCT03837379, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobile app ("Goal2Quit") packaged with nicotine replacement therapy (NRT) sampling. This integrated intervention will address the need for an easily disseminable, evidence-based, depression-specific cessation intervention for delivery via primary care.
Interventions
- BEHAVIORAL Treatment as Usual
- COMBINATION_PRODUCT Goal2Quit + NRT Sampling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2020-06-22 |
| Est. Completion | 2022-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03837379
The ClinicalTrials.gov registry entry for NCT03837379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT03837379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03837379 about?
NCT03837379 is a clinical study titled "Goal2Quit + NRT Sampling". The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobile app ("Goal2Quit") packaged with nicotine replacement therapy (NRT) sampling. This integrated inter...
What is the current status of trial NCT03837379?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2020-06-22. Estimated completion is 2022-05-18.
What interventions are being tested in trial NCT03837379?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Goal2Quit + NRT Sampling (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03837379?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.